Archives

JCM, Vol. 15, Pages 921: Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies

JCM, Vol. 15, Pages 921: Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies Journal of Clinical Medicine doi: 10.3390/jcm15030921 Authors: Reinhart Speeckaert Charlotte Delrue Marijn M. Speeckaert Background/Objectives: Diabetic kidney disease (DKD) is the most prevalent form of chronic kidney disease and kidney failure globally. In the last decade, RAAS inhibitors, SGLT2 inhibitors, GLP-1-receptor […]

Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology

For Immediate Release Chicago, IL – January 23, 2026 – Today, Zacks Equity Research discusses McKesson MCK, Cardinal Health CAH, West Pharmaceutical Services WST and Align Technology ALGN. Industry: Medical Supplies Link: https://www.zacks.com/commentary/2820960/4-medical-supply-stocks-poised-to-gain-in-a-prospering-industry The Zacks Medical – Dental Supplies industry in the Medical sector is likely to continue its upward momentum in 2026, backed by […]

Improved Drug Safety Needs Better Data Before AI

<div><p paraid=”913968553″ paraeid=”{e1d5cfca-2eb1-4873-94b9-a0e8a2b1d344}{9}”><strong>Contributed Commentary by Daniel O’Keeffe, Qinecsa </strong></p></div><div><p paraid=”87553613″ paraeid=”{e1d5cfca-2eb1-4873-94b9-a0e8a2b1d344}{17}”><strong>January 23, 2026</strong> | Applying artificial intelligence (AI) to fragmented and incomplete safety data cannot fill the gap left when the right information has not been captured during initial patient adverse event reporting. And yet, software vendors position the technology as a quick fix to safety data complexity. Although AI […]

Sun Pharma receives DCGI approval for generic version of semaglutide injection

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to a reduced calorie diet and increased physical activity.

Layer-by-Layer Polymeric Films: A Novel Approach to Buccal GLP-1 Delivery

Buccal delivery offers a promising alternative to oral drug administration by enabling direct systemic absorption and avoiding first-pass metabolism. Multilayer polymeric films represent a promising strategy for the sequential delivery of drug and absorption enhancer in the oral cavity. Here, dual- and triple-layer films were fabricated via slot-die coating, incorporating a GLP-1 receptor agonist (GLP-1-RA) […]